Cal-Maine
CALM
$75.12
-1.93%
Cal-Maine Foods Inc is the largest producer and marketer of shell eggs in the United States, operating within the Agricultural Farm Products industry. The company is a market leader, distinct for its vertically integrated operations and diverse portfolio that includes conventional, cage-free, organic, and nutritionally enhanced eggs under brands like Egg-Land's Best and Land O' Lakes. The current investor narrative is dominated by the stock's reaction to volatile egg commodity prices, with recent attention focused on a significant earnings beat that signaled a potential return to market stability, overshadowing a steep revenue decline, and the company's strategic use of its robust cash position for acquisitions to expand its geographic footprint.…
CALM
Cal-Maine
$75.12
Related headlines
Investment Opinion: Should I buy CALM Today?
Rating: Hold. The core thesis is that CALM is a high-quality company in a cyclical trough, but near-term earnings headwinds and a premium forward valuation warrant caution, making it a watchlist candidate rather than an immediate buy.
Supporting evidence includes a deeply discounted trailing PE of 3.83x, a fortress balance sheet with zero debt and $369.5M cash, robust TTM free cash flow of $1.17B supporting a 7.07% dividend yield, and a low beta of 0.298 for defensive characteristics. However, these strengths are counterbalanced by a 19.4% YoY revenue decline, gross margin compression to 26.95%, and a forward PE of 21.03x that implies significant earnings contraction ahead.
The thesis would upgrade to a Buy if the trailing PE remains below 5x while quarterly earnings demonstrate sequential stabilization, or if the stock breaks below $72 (52-week low) offering a greater margin of safety. It would downgrade to a Sell if revenue decline accelerates beyond 25% YoY or if the dividend appears unsustainable due to collapsing free cash flow. Relative to its own history, the stock is undervalued on a trailing basis but appears fairly valued to slightly overvalued on a forward-looking basis given the expected earnings decline.
Sign up to view all
CALM 12-Month Price Forecast
CALM is in the painful phase of its cycle where trailing metrics look cheap but forward estimates are falling. The pristine balance sheet and high dividend yield make it a compelling watchlist stock for value and income investors willing to tolerate cyclicality. However, with earnings likely to contract further and the stock in a technical downtrend, there is no clear near-term catalyst for a re-rating. The stance would upgrade to Bullish on evidence of margin stabilization (e.g., gross margin holding above 25% for two consecutive quarters) or a drop below the 52-week low offering a better entry point. It would turn Bearish if the dividend yield becomes unsupported by free cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cal-Maine's 12-month outlook, with a consensus price target around $97.66 and implied upside of +30.0% versus the current price.
Average Target
$97.66
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$60 - $98
Analyst target range
Analyst coverage is extremely limited, with only two analysts providing estimates, indicating this is a niche stock with minimal institutional research interest, which can lead to higher volatility and less efficient price discovery. The average revenue estimate for the period is approximately $2.99 billion, with a wide EPS range from $4.97 to $5.52, highlighting significant uncertainty in forecasting the company's earnings trajectory amid volatile commodity prices; recent institutional ratings from firms like BMO Capital and Stephens & Co. have consistently been 'Market Perform' or 'Equal-Weight', reflecting a neutral to cautious stance without major conviction for a near-term catalyst.
Bulls vs Bears: CALM Investment Factors
The evidence presents a classic value versus value trap scenario. The bull case is anchored in a historically cheap valuation (3.83x trailing PE), a pristine balance sheet, and strong cash generation, suggesting the market has over-penalized the stock for a cyclical downturn. The bear case highlights severe fundamental deterioration in revenue (-19.4% YoY) and margins, a concerning forward PE of 21.03x, and powerful technical downtrend. Currently, the bear side has stronger near-term evidence, as the stock's price action and forward multiple reflect ongoing earnings pressure. The single most important tension is whether the current trailing PE of 3.83x represents the cyclical trough (making it a deep value buy) or if forward earnings will collapse further, justifying the high forward multiple and potentially pushing the stock lower.
Bullish
- Extremely Low Trailing PE of 3.83x: The stock trades at a trailing PE of just 3.83x, near the bottom of its historical range (2.17x to 35x+). This deep discount prices in a severe earnings trough, offering significant upside if profitability stabilizes from current levels.
- Fortress Balance Sheet with Zero Debt: The company has zero debt, a robust current ratio of 6.38, and $369.5 million in cash. This financial strength provides a margin of safety and funds for strategic acquisitions, like the recent Creighton Brothers deal, without financial risk.
- Strong Profitability Despite Price Normalization: Even with a 19.4% YoY revenue decline, the company generated a net margin of 28.63% over the TTM and $102.8 million in net income last quarter. This demonstrates operational resilience and cost control in a cyclical downturn.
- Powerful Cash Generation for Shareholder Returns: The company generated $1.17 billion in free cash flow over the trailing twelve months. This supports a dividend yield of 7.07% and provides ample capital for reinvestment or opportunistic buybacks.
Bearish
- Severe Revenue & Margin Contraction: Revenue declined 19.4% YoY last quarter, continuing a sharp downtrend from a peak of $1.42 billion. Gross margin compressed to 26.95% from a high of 50.51%, indicating intense pressure from falling egg commodity prices.
- High Forward PE of 21.03x Signals Earnings Collapse: The forward PE of 21.03x is dramatically higher than the trailing PE of 3.83x, implying the market expects a severe near-term earnings drop. This premium forward multiple limits upside if earnings disappoint.
- Pronounced Technical Downtrend: The stock is down 19.91% over the past year and 14.01% in the past month, trading 40% below its 52-week high. This accelerating downtrend suggests persistent negative momentum and lack of buyer conviction.
- Limited Analyst Coverage & Neutral Sentiment: Only two analysts cover the stock, with consensus ratings of 'Market Perform' or 'Equal-Weight'. This limited institutional interest and lack of bullish catalysts can hinder price discovery and recovery.
CALM Technical Analysis
The stock is in a pronounced downtrend, having declined 19.91% over the past year. With a current price of $75.83, it is trading near the lower end of its 52-week range, approximately 40% above its 52-week low of $71.92 but 40% below its 52-week high of $126.4, indicating significant technical damage and positioning it as a potential value opportunity, albeit with the risk of being a 'falling knife' in a cyclical industry. Recent momentum shows a sharp short-term deterioration, with the stock down 14.01% over the past month, which contrasts with a modest 2.90% gain over the past three months; this 1-month plunge suggests the longer-term downtrend is accelerating, likely driven by negative sentiment around recent financial results. Key technical support is at the 52-week low of $71.92, while resistance is at the 52-week high of $126.4; a breakdown below support could signal a new leg down, while the stock's low beta of 0.298 indicates it is approximately 70% less volatile than the broader market, which may provide some downside cushion but also limits explosive upside potential.
Beta
0.30
0.30x market volatility
Max Drawdown
-39.2%
Largest decline past year
52-Week Range
$72-$126
Price range past year
Annual Return
-17.9%
Cumulative gain past year
| Period | CALM Return | S&P 500 |
|---|---|---|
| 1m | -4.1% | +9.3% |
| 3m | -3.0% | +4.6% |
| 6m | -17.6% | +6.1% |
| 1y | -17.9% | +34.6% |
| ytd | -4.3% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CALM Fundamental Analysis
Revenue is in a significant contraction phase, with the most recent quarterly revenue of $769.5 million representing a 19.4% year-over-year decline, continuing a multi-quarter downtrend from a peak of $1.42 billion in Q3 2025; this sharp decline reflects the normalization of egg prices from historic highs. The company remains profitable but under pressure, with net income of $102.8 million in the latest quarter and a trailing twelve-month net margin of 28.63%; however, gross margin has compressed to 26.95% in Q2 2026 from a high of 50.51% in Q3 2025, indicating a severe contraction in profitability as commodity prices fall. The balance sheet is exceptionally strong, featuring zero debt, a robust current ratio of 6.38, and substantial liquidity with $369.5 million in cash at the end of the last quarter; this is complemented by powerful cash generation, with free cash flow over the trailing twelve months of $1.17 billion, providing ample resources for strategic acquisitions and shareholder returns without financial risk.
Quarterly Revenue
$769498000.0B
2025-11
Revenue YoY Growth
-0.19%
YoY Comparison
Gross Margin
+0.26%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CALM Overvalued?
Given the positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is remarkably low at 3.83x, while the forward PE is significantly higher at 21.03x; this massive gap implies the market expects a severe near-term earnings contraction before a potential recovery, aligning with the cyclical nature of the business. Compared to sector averages, the stock trades at a deep discount on a trailing basis but a premium on a forward-looking basis; however, direct industry average data is not available in the provided dataset for a precise peer comparison. Historically, the current trailing PE of 3.83x is near the bottom of its own historical range, as seen in ratios from recent quarters that have fluctuated from as low as 2.17x to over 35x; trading at this depressed level suggests the market is pricing in pessimistic expectations for the earnings cycle trough, presenting a potential value opportunity if the company can stabilize profitability.
PE
3.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -100x~627x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
2.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the extreme volatility of earnings driven by commodity egg prices. Revenue has fallen 19.4% year-over-year, and gross margin has compressed from 50.51% to 26.95% in just three quarters, demonstrating high sensitivity to price swings. While the balance sheet is strong, the business model is inherently cyclical with earnings that can swing from over $10 per share to minimal levels, creating valuation uncertainty. The high forward PE of 21.03x indicates the market expects significant earnings decline, posing a risk of multiple compression if results are even worse.
Market & Competitive Risks include valuation compression given the stock trades at a premium forward multiple (21.03x) during a cyclical downturn, which could shrink further if sector sentiment sours. The stock's low beta of 0.298 suggests it is defensive but also may not participate fully in broader market rallies. Competitive risks are moderate given its market leadership, but the industry faces potential regulatory shifts (e.g., cage-free mandates) and consumer trends that require ongoing capital investment, as seen with the Creighton Brothers acquisition.
Worst-Case Scenario involves a deeper-than-expected trough in the egg price cycle, coupled with rising feed costs, squeezing margins further. This could lead to consecutive quarterly earnings misses, triggering analyst downgrades and a loss of dividend coverage confidence. The stock could re-test its 52-week low of $71.92, representing a downside of approximately -5% from the current $75.83. A more severe scenario, aligning with the stock's maximum drawdown of -39.21%, could see a decline towards the $60s if the market prices in a prolonged earnings depression, implying a potential loss of -20% or more.
FAQ
The primary risk is cyclical earnings volatility tied to commodity egg prices, evidenced by the 19.4% revenue decline and gross margin compression from 50.51% to 26.95%. Second is valuation risk: the high forward PE of 21.03x could compress further if earnings disappoint. Third is technical risk, as the stock is in a pronounced downtrend, down 19.91% over the past year and trading 40% below its high. A secondary risk is limited analyst coverage (only 2 analysts), which can lead to higher volatility and less efficient price discovery.
The 12-month outlook is framed by three scenarios. The Base Case (60% probability) sees the stock range-bound between $75 and $95 as earnings contract to an EPS near $5.25. The Bull Case (25% probability) targets $100 to $126 on faster-than-expected margin stabilization and positive capital allocation news. The Bear Case (15% probability) risks a drop to $65-$72 if earnings miss forecasts and technical support breaks. The most likely outcome is the Base Case, assuming the cyclical downturn continues as expected without new major shocks, with the high dividend yield providing a floor.
CALM sends mixed valuation signals. On a trailing basis, it is deeply undervalued with a PE of 3.83x, near the bottom of its historical range. This suggests the market has priced in a severe earnings depression. On a forward basis, it appears overvalued with a PE of 21.03x, implying the market expects earnings to collapse from current levels. The verdict depends on the time horizon: it is undervalued if current earnings represent a sustainable trough, but fairly valued or overvalued if earnings are set to fall sharply as the forward multiple suggests. The low Price-to-Cash-Flow of 3.80x indicates strong cash generation relative to price.
CALM is a situational buy, not a core growth holding. For a value investor seeking high yield (7.07%) and a margin of safety from a zero-debt balance sheet, it presents a compelling case at a trailing PE of 3.83x. However, given the severe revenue decline (-19.4% YoY) and the high forward PE of 21.03x signaling more pain ahead, it carries significant cyclical risk. It is a good buy for patient, income-focused investors who believe the egg price cycle is near a bottom and are willing to hold for the eventual recovery, potentially over 2-3 years.
CALM is unsuitable for short-term trading due to its low beta (0.298) limiting volatility-based gains and the lack of a near-term earnings catalyst. It is a long-term investment for investors who understand and can tolerate agricultural cycles. The minimum suggested holding period is 3-5 years to potentially ride through the full commodity cycle from trough to recovery. The 7.07% dividend yield supports a total return approach for income investors, but the principal value may remain depressed until earnings clearly inflect upward.
